Pharmafile Logo
Pharmafocus logo
Advanced Search

3,000 job losses to help AZ maintain profits and invest in R&D

February 9, 2007
Sales and Marketing AZ

AstraZeneca has indicated its plans to shed 3,000 jobs will mainly involve redundancies at its manufacturing facilities, in a renewed …

News

Momentum growing at specialists Archimedes as lead enters phase III

February 9, 2007
Research and Development

Specialist pharmaceutical company Archimedes has reached a vital stage in its plans for growth as its lead product enters phase …

News

Go-ahead for free prescriptions in Wales despite warnings

February 9, 2007
Sales and Marketing NHS, Wales

 Wales is set to abolish all NHS prescription charges to patients in a move intended to allow fairer access to …

News

Arrow purchase adds another string to AZ’s biotech bow

February 9, 2007
Research and Development

AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …

News

Novartis set for ‘unprecedented’ wave of launches

February 9, 2007
Sales and Marketing

Novartis is preparing to set a new record for the pharmaceutical industry by launching eight  products in the next 12 …

News

50% drop in UK sales positions reveals fast-changing industry

February 9, 2007
Sales and Marketing

Newly released figures show the number of sales representatives taking the ABPI exam dropped 50% in 2006; clear proof that …

News

Adventis expands into med ed with LeapFrog acquisition

February 8, 2007
Medical Communications

Marketing communications group Adventis has acquired med ed agency LeapFrog Medical for more than £2 million to form one of …

News

Fast-growing Roche leads pharma sector

February 7, 2007
Sales and Marketing

Roche has unveiled record-breaking profits for 2006, driven by pharma sales that grew by more than three times the market …

News

The evolution of the NHS in 2007

February 5, 2007
Sales and Marketing NHS, sales, strategy

The NHS will undergo major reorganisation in 2007, just as it has in the nine preceding years of Labour's tenure. …

Feature

GPs praised for dramatic fall in unnecessary referrals

January 31, 2007

The government has hailed the success of one of its key reforms, practice-based commissioning, saying it has helped some areas …

News

MorphoSys opens UK headquarters in Oxford

January 31, 2007
Research and Development

A leading producer of antibodies for biotech drug research and manufacturing has opened a new UK headquarters in Oxford.MorphoSys generates …

News

Charity to help patients fight on for bowel cancer drugs

January 29, 2007

NICE's decision not to recommend bowel cancer drugs on the NHS has left campaigners in fighting mood.The institute says Roche's …

News

Pharma’s eastern promise

January 29, 2007
Sales and Marketing China, India

Thanks to spiralling costs, increasing regulation and the ever-present threat of litigious action, it is hardly surprising that pharma companies …

Feature

More than 250 UK jobs axed as Pfizer downsizes

January 26, 2007
Sales and Marketing

Pfizer's UK salesforce is likely to be in the front line following the company's decision to slash more than 250 …

News

Packer Forbes scoops GSK Tycerb account

January 26, 2007
Medical Communications GSK, Packer Forbest

London-based agency Packer Forbes Communications has won its first breast cancer account, to promote GlaxoSmithKline's potential blockbuster, Tycerb.The agency beat …

News

Patient experience survey is discredited says BMA

January 26, 2007

A row is brewing between doctors and the Department of Health over a major survey aimed at gauging patients' experiences …

News

Lucentis approved in Europe

January 26, 2007
Sales and Marketing Lucentis, Novartis

European regulators have approved Novartis’ Lucentis, a new treatment for neovascular age-related macular degeneration, known as wet AMD.The company says …

News

Januvia set for EU approval

January 26, 2007
Sales and Marketing

Januvia, the first in a new class of diabetes treatments, is set for approval in the European Union.Marketed by Merck …

News

Merck Serono picks Huntsworth for infertility work

January 26, 2007
Medical Communications Huntsworth

Newly merged biopharmaceutical company Merck Serono has awarded Huntsworth Health the UK account for one of biggest selling drugs.The agency …

News

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025